AU2001230219A1 - 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy - Google Patents

4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy

Info

Publication number
AU2001230219A1
AU2001230219A1 AU2001230219A AU3021901A AU2001230219A1 AU 2001230219 A1 AU2001230219 A1 AU 2001230219A1 AU 2001230219 A AU2001230219 A AU 2001230219A AU 3021901 A AU3021901 A AU 3021901A AU 2001230219 A1 AU2001230219 A1 AU 2001230219A1
Authority
AU
Australia
Prior art keywords
pyrimidyl
pyridyl
alkyl
inhibitor
1beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230219A
Other languages
English (en)
Inventor
Stefan Laufer
Hans-Gunter Striegel
Karola Tollmann
Susanne Tries
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merckle GmbH
Original Assignee
Merckle GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle GmbH filed Critical Merckle GmbH
Publication of AU2001230219A1 publication Critical patent/AU2001230219A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2001230219A 2000-02-01 2001-01-31 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy Abandoned AU2001230219A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10004157 2000-02-01
DE10004157A DE10004157A1 (de) 2000-02-01 2000-02-01 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie
PCT/EP2001/001011 WO2001057042A2 (fr) 2000-02-01 2001-01-31 Derives de pyrrole 4-pyridyl- et 2,4-pyrimidinyl-substitues et leur utilisation en pharmacie

Publications (1)

Publication Number Publication Date
AU2001230219A1 true AU2001230219A1 (en) 2001-08-14

Family

ID=7629335

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230219A Abandoned AU2001230219A1 (en) 2000-02-01 2001-01-31 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy

Country Status (16)

Country Link
US (1) US6867211B2 (fr)
EP (1) EP1252163B1 (fr)
JP (1) JP2003525227A (fr)
KR (1) KR20030005176A (fr)
CN (1) CN1206230C (fr)
AT (1) ATE250608T1 (fr)
AU (1) AU2001230219A1 (fr)
CA (1) CA2398111C (fr)
DE (2) DE10004157A1 (fr)
DK (1) DK1252163T3 (fr)
ES (1) ES2208548T3 (fr)
MX (1) MXPA02007403A (fr)
NO (1) NO323246B1 (fr)
PT (1) PT1252163E (fr)
TR (1) TR200301898T4 (fr)
WO (1) WO2001057042A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10001166A1 (de) 2000-01-13 2001-07-19 Merckle Gmbh Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung
BR0212244A (pt) 2001-08-30 2004-10-05 Merckle Gmbh Uso de um ou mais do que um composto e seus isÈmeros ópticos, derivados e sais fisiologicamente aceitáveis, composição farmacêutica, e, método de tratamento ou de prevenção da degeneração ou da destruição de cartilagem articular e/ou de osso subcondral em uma ou mais articulações de um mamìfero
US6849627B2 (en) 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7087615B2 (en) 2001-09-20 2006-08-08 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
EP1549635A1 (fr) * 2002-09-27 2005-07-06 Janssen Pharmaceutica N.V. Pyrroles 3,4-disubstitues et utilisation de ceux-ci pour le traitement de maladies inflammatoires
ATE426605T1 (de) * 2003-06-12 2009-04-15 Merck & Co Inc Inhibitoren von mitotischem kinesin
GB0520958D0 (en) * 2005-10-14 2005-11-23 Cyclacel Ltd Compound
EP1884239A1 (fr) * 2006-07-28 2008-02-06 Merckle Gmbh Composes de pyrrole anneles pour traiter le cancer
GB0816759D0 (en) * 2008-09-12 2008-10-22 Selcia Ltd Compounds
WO2017151409A1 (fr) 2016-02-29 2017-09-08 University Of Florida Research Foundation, Incorporated Méthodes de chimiothérapie

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920672A (en) 1974-08-22 1975-11-18 Syntex Inc Thiacycl (2.2.2.)azine carboxylic acids
JPS56100784A (en) 1980-01-16 1981-08-12 Yoshitomi Pharmaceut Ind Ltd Indolizine derivative
US4536512A (en) 1982-10-08 1985-08-20 Merck & Co., Inc. 5-(2,3-Dihydro-1H-pyrrolizin-5-oyl)-2,3-dihydro-1H-pyrrolizine-1-alkanoic or carboxylic acids and use thereof as anti-inflammatory and analgesic agents
US4539400A (en) * 1983-01-13 1985-09-03 Rhone-Poulenc Sante Pyridin-3-yl substituted ortho-fused pyrrole derivatives
FR2539417A1 (fr) 1983-01-13 1984-07-20 Rhone Poulenc Sante Nouveaux pyrrolo-1, 2 heterocycles, leur preparation et les medicaments qui les contiennent
US4560699A (en) 1983-01-17 1985-12-24 Syntex (U.S.A.) Inc. 5-(4-Vinylbenzoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof and use as analgesics and anti-inflammatories
FR2557111B1 (fr) 1983-12-21 1986-04-11 Rhone Poulenc Sante Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent
US4719218A (en) 1985-12-12 1988-01-12 Smithkline Beckman Corporation Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor
US4873340A (en) * 1986-05-29 1989-10-10 Syntex (U.S.A.) Inc. Process for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-A]pyrrole-1,1-dicarboxylates
FR2617484B1 (fr) 1987-07-02 1989-10-20 Rhone Poulenc Sante Procede de preparation de l'acide (pyridyl-3)-3 1h-3h-pyrrolo (1,2-c) thiazolecarboxylique-7 dextrogyre
DE3732135A1 (de) 1987-09-24 1989-04-13 Deutsche Forsch Luft Raumfahrt Entladungskanal fuer hochleistungslaser
US5260451A (en) 1989-05-11 1993-11-09 Merckle Gmbh Substituted pyrrole compounds and use thereof in pharmaceutical compositions
DE3915450A1 (de) * 1989-05-11 1990-11-15 Gerd Prof Dr Dannhardt Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
WO1991000093A1 (fr) * 1989-06-26 1991-01-10 The Research Foundation Of State University Of New York Derives de bis-acyloxymethyle
IE922293A1 (en) * 1991-07-17 1993-01-27 Abbott Lab Platelet activating factor antagonists
JPH05289267A (ja) 1992-04-07 1993-11-05 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
DE69419327D1 (de) 1993-01-21 1999-08-12 Konishiroku Photo Ind Ein farbphotographisches Silberhalogenidmaterial
DE4419315A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419246A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419247A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
US5552422A (en) 1995-01-11 1996-09-03 Merck Frosst Canada, Inc. Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
DE19845446A1 (de) 1998-10-02 2000-04-06 Merckle Gmbh Antiinflammatorische Oxo- und Hydroxyderivate von Pyrrolizinen und deren Verwendung in der Pharmazie
GB2363585B (en) 1999-06-24 2003-08-27 Tuboscope I P Inc A screen a panel for a screen a shale shaker and a method of screening
US7640571B1 (en) 1999-07-15 2009-12-29 General Instrument Corporation Method and apparatus for preventing disruptions in set-top terminal function due to the download of updated programming or data to the set-top terminal
EP1232158B1 (fr) 1999-11-23 2004-02-25 Merckle Gmbh Derives oxo et hydroxy anti-inflammatoires de pyrrolizines et leur application pharmaceutique
DE10001166A1 (de) 2000-01-13 2001-07-19 Merckle Gmbh Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung

Also Published As

Publication number Publication date
DK1252163T3 (da) 2004-01-19
WO2001057042A2 (fr) 2001-08-09
TR200301898T4 (tr) 2004-01-21
MXPA02007403A (es) 2004-04-05
JP2003525227A (ja) 2003-08-26
PT1252163E (pt) 2004-02-27
DE50100678D1 (de) 2003-10-30
CN1396923A (zh) 2003-02-12
CA2398111C (fr) 2008-08-12
EP1252163B1 (fr) 2003-09-24
KR20030005176A (ko) 2003-01-17
CA2398111A1 (fr) 2001-08-09
EP1252163A2 (fr) 2002-10-30
US20030153558A1 (en) 2003-08-14
WO2001057042A3 (fr) 2001-12-27
CN1206230C (zh) 2005-06-15
US6867211B2 (en) 2005-03-15
ATE250608T1 (de) 2003-10-15
ES2208548T3 (es) 2004-06-16
DE10004157A1 (de) 2001-08-02
NO323246B1 (no) 2007-02-12
NO20023634L (no) 2002-09-25
NO20023634D0 (no) 2002-07-31

Similar Documents

Publication Publication Date Title
AU2001230219A1 (en) 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
IL158589A (en) Carboxylic acid substituted oxazole derivatives, process for their manufacture, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment and prophylaxis of diseases which are modulated by ppar-alpha and -gamma activators
DK1175214T3 (da) Cyclooxygenase-2-hæmmer-kompositioner med hurtig indtræden af terapeutisk virkning
WO2009047798A3 (fr) Dérivés acétamide comme activateur de la glucokinase, leur procédé et applications médicinales
AUPR213700A0 (en) Antiviral agents
WO2008020040A3 (fr) Utilisation de composés et de dérivés de 2,5-dihydroxybenzène pour le traitement de la fibrose
DK2295052T3 (da) Anvendelse af ritonavir til forbedring af farmakokinetikken af lægemidler, der metaboliseres af cytochrom P450
AU2002346973A1 (en) Oral Dosage Form for Propiverine or its Pharmaceutically Acceptable Salts with an Extended Release of the Active Ingredient
SI1441734T1 (sl) Dihidropirimidin karboksamidni inhibitorji HIV-integraze
GEP20084304B (en) Use of 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
DE60315796D1 (de) Hydroxynaphthyridinoncarbonsäureamide, die sich als inhibitoren der hiv-integrase eignen
NO20062398L (no) Daglig, oral, kontrollert frigivnings oksycodon-doserings form
WO2003062200A3 (fr) Cycloalkanoindoles a substitution fluor, compositions contenant de tels composes, et procedes de traitement
WO2006067165A3 (fr) Medicaments pour le traitement ou la prevention de maladies fibrotiques
WO2008132138A9 (fr) Dérivés d'aminopyrimidines disubstituées en 4 et en 6
MXPA03010285A (es) Derivados de furano y tiofeno que activan receptores activados por el proliferador de peroxisoma humana.
ECSP055915A (es) Combinación farmacéutica para la prevención o la terapia de enfermedades cardiovasculares, cardiopulmonares, pulmonares o renales
WO2006121831A3 (fr) Inhibiteurs de l'intégrase du vih
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
MX2012006485A (es) Piridinon hidroxiclicopentil carboxamidas: inhibidores de la integrasa del vih con aplicaciones terapeuticas.
WO2003002064A3 (fr) Composes heterocycliques tenant lieu d'inhibiteurs selectifs de dhfr bacterienne, et utilisations
EP1256344A4 (fr) Remedes contre les maladies induites par l'endotheline
MY133107A (en) Use of pyrimidine derivatives for the prophylaxis and therapy of cerebral ischemia
SE9900070D0 (sv) New use
AU2001233757A1 (en) Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases